( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
Blood sugar control is at the center of any diabetes treatment plan. High blood sugar, or hyperglycemia, is a major concern. People with diabetes get hypoglycemia (low blood sugar) when their ...